491 related articles for article (PubMed ID: 25255434)
1. Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: Synthesis, cytotoxic activity and molecular modeling.
Ghorab MM; Ceruso M; Alsaid MS; Nissan YM; Arafa RK; Supuran CT
Eur J Med Chem; 2014 Nov; 87():186-96. PubMed ID: 25255434
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT
Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
[TBL] [Abstract][Full Text] [Related]
4. Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
Khloya P; Ceruso M; Ram S; Supuran CT; Sharma PK
Bioorg Med Chem Lett; 2015 Aug; 25(16):3208-12. PubMed ID: 26105196
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
[TBL] [Abstract][Full Text] [Related]
6. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties.
Alafeefy AM; Abdel-Aziz HA; Vullo D; Al-Tamimi AM; Awaad AS; Mohamed MA; Capasso C; Supuran CT
J Enzyme Inhib Med Chem; 2015 Feb; 30(1):52-6. PubMed ID: 24666294
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives.
Awadallah FM; El-Waei TA; Hanna MM; Abbas SE; Ceruso M; Oz BE; Guler OO; Supuran CT
Eur J Med Chem; 2015; 96():425-35. PubMed ID: 25912674
[TBL] [Abstract][Full Text] [Related]
10. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
[TBL] [Abstract][Full Text] [Related]
11. Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and II.
Knaus EE; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2011 Oct; 21(19):5892-6. PubMed ID: 21852133
[TBL] [Abstract][Full Text] [Related]
12. Pyrrolo and pyrrolopyrimidine sulfonamides act as cytotoxic agents in hypoxia via inhibition of transmembrane carbonic anhydrases.
Khalil OM; Kamal AM; Bua S; El Sayed Teba H; Nissan YM; Supuran CT
Eur J Med Chem; 2020 Feb; 188():112021. PubMed ID: 31901743
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Szafrański K; Vullo D; Supuran CT
Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.
Winum JY; Dogné JM; Casini A; de Leval X; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
J Med Chem; 2005 Mar; 48(6):2121-5. PubMed ID: 15771455
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 6-tetrazolyl-substituted sulfocoumarins acting as highly potent and selective inhibitors of the tumor-associated carbonic anhydrase isoforms IX and XII.
Grandane A; Tanc M; Zalubovskis R; Supuran CT
Bioorg Med Chem; 2014 Mar; 22(5):1522-8. PubMed ID: 24513186
[TBL] [Abstract][Full Text] [Related]
17. New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: biological evaluation and molecular modelling studies.
Carradori S; Mollica A; Ceruso M; D'Ascenzio M; De Monte C; Chimenti P; Sabia R; Akdemir A; Supuran CT
Bioorg Med Chem; 2015 Jul; 23(13):2975-81. PubMed ID: 26007302
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
Ibrahim DA; Lasheen DS; Zaky MY; Ibrahim AW; Vullo D; Ceruso M; Supuran CT; Abou El Ella DA
Bioorg Med Chem; 2015 Aug; 23(15):4989-4999. PubMed ID: 26048024
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII.
Güzel O; Maresca A; Scozzafava A; Salman A; Balaban AT; Supuran CT
Bioorg Med Chem Lett; 2009 Jun; 19(11):2931-4. PubMed ID: 19410461
[TBL] [Abstract][Full Text] [Related]
20. Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies.
Mollica A; Costante R; Akdemir A; Carradori S; Stefanucci A; Macedonio G; Ceruso M; Supuran CT
Bioorg Med Chem; 2015 Sep; 23(17):5311-8. PubMed ID: 26264840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]